Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Provision of outsourced development services on a global basis to the pharmaceutical, biotechnology8.12B100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
U.S.3.28B40.44%
Ireland2.38B29.27%
Rest of Europe1.57B19.39%
Other884.5M10.89%
